Structure Therapeutics, Inc. (GPCR)
39.12
-1.72
(-4.22%)
USD |
NASDAQ |
May 07, 16:00
39.00
-0.12
(-0.29%)
After-Hours: 20:00
Structure Therapeutics Research and Development Expense (Annual) : 225.85M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Viking Therapeutics, Inc. | 344.96M |
| Novo Nordisk A/S | 6.838B |
| Revolution Medicines, Inc. | 978.68M |
| Kymera Therapeutics, Inc. | 308.26M |